Published

The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Mental Wellness
Date: 2026-04-21
Source: Crossref
DOI: 10.4081/mw.2026.40
PubMed: Unavailable

Authors

Khosravi Mohsen De Berardis Domenico Tusconi Massimo

Watch author

Derived topics and classifications

psilocybin Depression Clinical Trial Meta-Analysis Systematic Review Review Article Treatment-Resistant Depression Safety Meta-Analysis

Citation graph

26 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1176/ajp.2006.163.11.1905 10.1038/npp.2017.84 10.1177/0269881114548296 10.1177/0269881116675513 10.1177/0269881116675512 10.1073/pnas.1119598109 10.1038/s41583-020-0367-2 10.1001/jamapsychiatry.2020.3285 10.1177/02698811211073759 10.1056/nejmoa2032994 10.1176/appi.ajp.2019.19010035 10.1016/j.neuropharm.2017.12.040

Indexed papers citing this DOI

The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes2026-04-21

Related papers

G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?Ask the expert - Psychedelic substances · 2024-08-31 S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-19 Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)ClinicalTrials.gov · 2026-07-09 Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)ClinicalTrials.gov · 2025-10-07 Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10 Does Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled TrialClinicalTrials.gov · 2026-05-07 Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.ClinicalTrials.gov · 2025-09-10 The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography StudyClinicalTrials.gov · 2024-04-19